
Please try another search
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers RDT platforms, including AtomoRapid Pascal, Curie, Galileo, and Elion for blood tests. It also offers Atomo application, a custom mobile application for self-test users, as well as provides digital health solutions. In addition, it provides HIV Rapid self-Tests. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Name | Age | Since | Title |
---|---|---|---|
John Michael Kelly | - | 2010 | Founder, CEO, MD & Interim Chair |
Ian Boulton | - | - | Member of Advisory Board |
Cheri L. Walker | - | 2022 | Independent Non-Executive Director |
Anthony May | - | 2025 | Independent Non-Executive Director |
Patrick Cook | - | 2025 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review